Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 28, 2019; 25(4): 457-468
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.457
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.457
Table 2 Comparison of characteristics among patients receiving low-dose aspirin in the continuous low-dose aspirin group and the discontinuous low-dose aspirin group
Continuous LDA (n = 95) | Discontinuous LDA (n = 59) | P value | |
Age, mean (SD), yr | 75.5 (6.841) | 75.7 (7.684) | 0.856 |
Sex, male, n (%) | 71 (74.7) | 46 (78.0) | 0.701 |
BMI, mean (SD), yr | 22.7 (3.395) | 23.1 (3.079) | 0.382 |
Comorbidity, n (%) | |||
Hypertension | 70 (73.7) | 39 (66.1) | 0.364 |
Diabetes mellitus | 32 (33.7) | 21 (35.6) | 0.862 |
Renal failure | 7 (7.4) | 4 (6.8) | > 0.99 |
Coronary artery diseases | 78 (82.1) | 42 (71.2) | 0.161 |
Longitudinal location, n (%) | |||
Upper | 18 (18.9) | 7 (11.9) | 0.429 |
Middle | 40 (42.1) | 24 (40.7) | |
Lower | 37 (39.0) | 28 (47.5) | |
Macroscopic findings, n (%) | |||
Depressed | 31 (32.6) | 21 (35.6) | 0.729 |
Non-depressed | 64 (67.4) | 38 (64.4) |
- Citation: Harada H, Suehiro S, Murakami D, Nakahara R, Nagasaka T, Ujihara T, Sagami R, Katsuyama Y, Hayasaka K, Amano Y. Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy. World J Gastroenterol 2019; 25(4): 457-468
- URL: https://www.wjgnet.com/1007-9327/full/v25/i4/457.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i4.457